☆ 4.8 Article

Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Multidisciplinary Sciences

Tertiary lymphoid structures in cancer

Ton N. Schumacher et al.

Summary: This article discusses the current knowledge on TLSs in cancer, focusing on the drivers of TLS formation, the function and contribution of TLSs to the antitumor immune response, and the potential of TLSs as therapeutic targets in human cancers.

SCIENCE (2022)

添加到收藏夹

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Oncology

CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer

Moran Yang et al.

Summary: This study reveals the critical role of CXCL13 in shaping the antitumor microenvironment by facilitating the maintenance of CXCR5(+)CD8(+) T cells in TLSs, and supports a clinical investigation for a combination of CXCL13 and PD-1 blockade therapy in HGSC.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

添加到收藏夹

Review Oncology

Therapeutic Targeting of checkpoint Receptors within the DnAM1 Axis

Zoya Alteber et al.

Summary: Therapeutic antibodies targeting the CTLA4/PD-1 pathways have revolutionized cancer immunotherapy, but relapse following early response due to resistance remains a common issue. The DNAM1 axis, which includes TIGIT, PVRIG, and CD96, has shown promise in cancer clinical trials as a potent coregulator of innate and adaptive immunity. Ongoing studies are investigating the use of DNAM1 axis blockers in combination with anti-PD-1/PD-L1 agents to overcome resistance.

CANCER DISCOVERY (2021)

添加到收藏夹

Article Oncology

The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer

William Freed-Pastor et al.

Summary: The CD155/TIGIT axis can be utilized for immune evasion in chronic viral infections and cancers like pancreatic adenocarcinoma. Studies have shown that a significant portion of PDAC patients have predicted high-affinity MHC class I-restricted neoepitopes, and modulation of the CD155/TIGIT axis can promote immune evasion in PDAC. In preclinical models, a combination immunotherapy targeting TIGIT/PD-1 plus CD40 agonism has shown promising anti-tumor responses.

CANCER CELL (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Ovarian Cancer Immunotherapy and Personalized Medicine

Susan Morand et al.

Summary: Response to immunotherapy in ovarian cancer is limited, but stratification by tumor biomarkers may improve predictiveness. Future directions include utilizing these biomarkers to select ideal candidates, increasing the likelihood of success with immunotherapy in ovarian cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Editorial Material Oncology

Immunotherapy in ovarian cancer: we are not there yet

Emma Barber et al.

LANCET ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Targeting FAK in anticancer combination therapies

John C. Dawson et al.

Summary: Focal adhesion kinase (FAK) is commonly overexpressed in cancer and involved in various oncogenic processes and resistance mechanisms, making FAK inhibitors most effective as combination therapies in selected patient populations.

NATURE REVIEWS CANCER (2021)

添加到收藏夹

Article Oncology

Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer

Shuang Zhang et al.

Summary: Genetically informed, immunocompetent tumor models are crucial for evaluating conventional, targeted, and immune therapies. By engineering mouse fallopian tube organoids, researchers were able to study the effects of specific mutations found in high-grade serous tubo-ovarian cancer (HGSC) models, leading to the development of effective combination treatments for different genetic subgroups of HGSC. These findings highlight the importance of genotype-informed, syngeneic organoid models for understanding tumor biology and therapeutic responses.

CANCER DISCOVERY (2021)

添加到收藏夹

Article Oncology

Genetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of Combination Immunothrapy

Sonia Iyer et al.

Summary: The study developed a series of mouse models carrying genotypes of human high-grade serous tubo-ovarian carcinomas (HGSC) that can grow in syngeneic immunocompetent hosts, recapitulating human disease characteristics, including genotype-driven responses to treatment. The research identified follistatin as a driver of resistance to checkpoint inhibitors.

CANCER DISCOVERY (2021)

添加到收藏夹

Review Oncology

Directing Traffic: How to Effectively Drive T Cells into Tumors

Annabelle J. Anandappa et al.

CANCER DISCOVERY (2020)

添加到收藏夹

Article Biology

T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity

Marta Canel et al.

ELIFE (2020)

添加到收藏夹

Article Oncology

The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers

Julian Smazynski et al.

GYNECOLOGIC ONCOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Cancer associated fibroblast FAK regulates malignant cell metabolism

Fevzi Demircioglu et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Medicine, Research & Experimental

FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer

Sonia Zaghdoudi et al.

EMBO MOLECULAR MEDICINE (2020)

添加到收藏夹

News Item Biotechnology & Applied Microbiology

Antibody engineers seek optimal drug targeting TIGIT checkpoint

Elie Dolgin

NATURE BIOTECHNOLOGY (2020)

添加到收藏夹

Article Oncology

Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors

Denarda Dangaj et al.

CANCER CELL (2019)

添加到收藏夹

Article Biology

FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy

Carlos J. Diaz Osterman et al.

ELIFE (2019)

添加到收藏夹

Article Oncology

Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma

Lei Wu et al.

CANCER IMMUNOLOGY RESEARCH (2019)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Jerome Galon et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

添加到收藏夹

Review Oncology

Tertiary lymphoid structures in the era of cancer immunotherapy

Catherine Sautes-Fridman et al.

NATURE REVIEWS CANCER (2019)

添加到收藏夹

Article Immunology

Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity

Karen O. Dixon et al.

JOURNAL OF IMMUNOLOGY (2018)

添加到收藏夹

Review Immunology

Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity

Victor H. Engelhard et al.

JOURNAL OF IMMUNOLOGY (2018)

添加到收藏夹

Article Immunology

Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity

Qing Zhang et al.

NATURE IMMUNOLOGY (2018)

添加到收藏夹

Review Multidisciplinary Sciences

Cancer immunotherapy using checkpoint blockade

Antoni Ribas et al.

SCIENCE (2018)

添加到收藏夹

Editorial Material Oncology

A Critical need for Better Cancer Immunotherapy Models: Are Organotypic Tumor spheroid Cultures the Answer?

Justin M. Balko et al.

CANCER DISCOVERY (2018)

添加到收藏夹

Review Oncology

TIGIT: a novel immunotherapy target moving from bench to bedside

Benjamin L. Solomon et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)

添加到收藏夹

Review Oncology

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

Spencer C. Wei et al.

CANCER DISCOVERY (2018)

添加到收藏夹

Article Biology

Topography of cancer-associated immune cells in human solid tumors

Jakob Nikolas Kather et al.

ELIFE (2018)

添加到收藏夹

Review Oncology

Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics

Curtis W. McCloskey et al.

CANCERS (2018)

添加到收藏夹

Article Oncology

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

Ellen L. Goode et al.

JAMA ONCOLOGY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

QuPath: Open source software for digital pathology image analysis

Peter Bankhead et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Review Oncology

CD155, an onco-immunologic molecule in human tumors

Jian Gao et al.

CANCER SCIENCE (2017)

添加到收藏夹

Article Oncology

Immunotherapy in ovarian cancer

K. Odunsi

ANNALS OF ONCOLOGY (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

Hui Zhang et al.

CELL (2016)

添加到收藏夹

Article Oncology

Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer

David R. Kroeger et al.

CLINICAL CANCER RESEARCH (2016)

添加到收藏夹

Review Immunology

Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation

Ana C. Anderson et al.

IMMUNITY (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression

Hanane Laklai et al.

NATURE MEDICINE (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

Hong Jiang et al.

NATURE MEDICINE (2016)

添加到收藏夹

Article Medicine, General & Internal

Ovarian cancer

Ursula A. Matulonis et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

添加到收藏夹

Review Oncology

Tumor infiltrating lymphocytes in ovarian cancer

Phillip P. Santoiemma et al.

CANCER BIOLOGY & THERAPY (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity

Alan Serrels et al.

CELL (2015)

添加到收藏夹

Article Medicine, Research & Experimental

TIGIT predominantly regulates the immune response via regulatory T cells

Sema Kurtulus et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

添加到收藏夹

Editorial Material Oncology

nCounter® PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA)

Alessandra Cesano

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)

添加到收藏夹

Review Immunology

Molecular and cellular insights into T cell exhaustion

E. John Wherry et al.

NATURE REVIEWS IMMUNOLOGY (2015)

添加到收藏夹

Article Oncology

The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function

Robert J. Johnston et al.

CANCER CELL (2014)

添加到收藏夹

Article Cell Biology

Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function

Christine Jean et al.

JOURNAL OF CELL BIOLOGY (2014)

添加到收藏夹

Review Oncology

FAK in cancer: mechanistic findings and clinical applications

Florian J. Sulzmaier et al.

NATURE REVIEWS CANCER (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Jianjiong Gao et al.

SCIENCE SIGNALING (2013)

添加到收藏夹

Article Oncology

Development of a syngeneic mouse model for events related to ovarian cancer

KF Roby et al.

CARCINOGENESIS (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.